- Website
- ncardia.com
- Total Funding
- $60.0M
- Last Round
- $60.0M Venture RoundNov 2021
- Rounds
- 2
About
Ncardia is a Biotech company. It has raised $60.0M in total across 2 rounds, most recently a $60.0M Venture Round round in Nov 2021. Investors include InnovationQuarter, SRIW and Sambrinvest.
Funding History
Nov 2021
Sign up to see all 2 rounds
Venture Round through Growth Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ncardia"><img src="https://indexed.vc/api/badge/company/ncardia" alt="Ncardia on Indexed.vc" width="260" height="76" /></a>